Broker News

Robinhood Nearing Settlement in Meme Stock Case

In a May 28 filing, Robinhood’s lawyers indicated that the company is finalizing a settlement with investors and expects to resolve the case within two weeks.

The investors, led by Blue Laine-Beveridge, claimed that Robinhood manipulated the market and caused financial losses by restricting trades in GameStop, AMC, and other popular stocks.

From January 28 to February 4, 2021, Robinhood restricted trading to meet clearinghouse deposit requirements, sparking customer outrage and regulatory scrutiny.

This lawsuit is among several Robinhood faces over its handling of the meme stock surge. Robinhood denies any wrongdoing, stating the restrictions were necessary for protection.

The settlement follows US District Judge Cecilia Altonaga’s rejection of the investors’ motion for class certification in April, denying a similar request earlier in November.

Robinhood’s shares, which have fallen significantly since their IPO last year, gained 3% on Wednesday, closing above $21. This year, HOOD shares are up over 65%, though down 35% from their IPO price.

Related Post

Robinhood Dominates in Resurgence of Meme Stocks

This month saw a resurgence in meme stocks, fueled by the cryptocurrency market. Despite past criticism, Robinhood re-emerged as a leader in this trend.

CEO Vlad Tenev noted that May 14 was one of the biggest trading days in a year, with daily equities trading volume reaching $5 billion. April’s total monthly volume was $70.7 billion, a drop from the previous month’s $87.7 billion. By April 2023, Robinhood handled just $38.9 billion in equities trading volume.

A single tweet reignited the meme stock frenzy in 2024. Keith Gill, known as “Roaring Kitty,” posted a meme indicating things were getting serious, sparking the frenzy.

GME shares soared by nearly 500% at one point but settled with a 90% gain in May, the highest since August 2023.

Robinhood also announced its first share buyback plan, intending to repurchase $1 billion over the next 2-3 years.

User Review
0 (0 votes)

Recent Posts

  • Stock News

Alnylam Stock Surges 38% to $225.35 on Heart Drug Success

Quick Look: Alnylam's stock surged 38% to $225.35 after positive study results for its heart…

9 hours ago
  • Technology News

Belgium’s New Digital ID Wallet Secured by Cryptomathic

Quick Look: Belgium introduces a new digital ID wallet, secured by Cryptomathic, aligning with EU…

10 hours ago
  • Technology News

Microsoft G42 Investment Cuts UAE’s Ties with Huawei

On Monday, sources claim that the Microsoft deal to invest in G42 is said to…

11 hours ago
  • Stock News

Nvidia Stock Tumbles, Extending Slump to Three Days

On Monday, Nvidia shares dropped 6.70% lower, lengthening their losses for a third consecutive period,…

11 hours ago
  • Commodity News

Oil Prices Stable Amid China Recovery, Supply Concerns

Oil prices were steady on Tuesday as traders assessed concerns over China’s rebound outlook and…

17 hours ago
  • Stock News

Denali Therapeutics Set for Growth with $40.22 Target Price

Quick Look: Analyst Ratings: Denali Therapeutics holds a "Moderate Buy" with an average target price…

1 day ago

This website uses cookies.